Painless Colonoscopy
Conditions
Interventions
Propofol group:5ug/kg of alfentanil and propofol (1.5mg/kg)
Remazolam group:5ug/kg of alfentanil and remimazolam (1.5mg/kg)
Sponsors
Weifang People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients receiving painless colonoscopy diagnosis and treatment; 2. Aged 18-65 years, gender is not limited; 3. ASA I-II grade; 4. BMI 18-30kg/m^2; 5. Informed consent, voluntarily participate in the trial, and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe heart, brain, lung, liver, kidney and metabolic diseases; 2. Systolic blood pressure > 180mmHg and (or) diastolic blood pressure > 110mmHg in patients with preoperative blood pressure, or 40%/150ml of wine); 6. Those who are allergic to or have contraindications to aniline azepines, opioids, propofol, lidocaine and their drug components; 7. Subjects deemed unsuitable by the investigator to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative adverse events occurred ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Effectiveness index;vital signs;Safety index;Satisfaction evaluation ; | — |
Countries
China
Contacts
Public ContactCheng Xiaoyan
Weifang People's Hospital
Outcome results
None listed